Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2020
Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinomaM Herman Chui, Amir Momeni Boroujeni, Diana Mandelker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 2, 2023
The Significance of International Federation of Gynecology and Obstetrics Grading in Microsatellite Instability-High and POLE-Mutant Endometrioid Endometrial CarcinomaElizabeth Kertowidjojo, Amir Momeni-Boroujeni, Eric Rios-Doria, et al.
The American Journal of Surgical Pathology|April 1, 2022
Outcome-based Validation of Confluent/Expansile Versus Infiltrative Pattern Assessment and Growth-based Grading in Ovarian Mucinous CarcinomaAmir Momeni-Boroujeni, HyoChan Song, Lina Irshaid, et al.
BMC Veterinary Research|May 6, 2025
Evaluation of a new method of selective dry cow treatment using microbiological culture and antibiogram resultsHossein Navaei, Mehdi Vodjgani, Babak Khoramian, et al.
The American Journal of Surgical Pathology|October 23, 2025
FGFR1 Mutations Are Rare Alternate Oncogenic Drivers in FOXL2-Wildtype Adult Granulosa Cell Tumors of the OvaryDavid L Kolin, Douglas A Mata, Douglas I Lin, et al.
Journal of Liposome Research|January 29, 2013
Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasisArash Momeni, Morteza Rasoolian, Amir Momeni, et al.
JCO Precision Oncology|March 21, 2025
Retrospective Analysis of <i>BRCA</i>-Altered Uterine Sarcoma Treated With Poly(ADP-ribose) Polymerase InhibitorsMara Rao, Madeline Merrill, Megan Troxel, et al.
Gynecologic Oncology|November 7, 2024
Evolutionary pathways in early-stage, non-myoinvasive endometrioid endometrial cancers of no specific molecular profileSara Moufarrij, Yulia Lakhman, Carol Aghajanian, et al.
The Journal of Pathology. Clinical Research|September 10, 2021
Somatic intronic TP53 c.375+5G mutations are a recurrent but under-recognized mode of TP53 inactivationM Herman Chui, Ciyu Yang, Nikita Mehta, et al.
Pageof 8